Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

Title
Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
Authors
Keywords
Epicardial fat, Ipragliflozin, Normal weight, Sodium-glucose co-transporter-2 inhibitors, Type 2 diabetes, Visceral obesity
Journal
Diabetes Therapy
Volume 8, Issue 4, Pages 851-861
Publisher
Springer Nature
Online
2017-06-14
DOI
10.1007/s13300-017-0279-y

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started